{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T04:16:21Z","timestamp":1727496981166},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,26]]},"DOI":"10.7759\/cureus.70297","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:48:41Z","timestamp":1727419721000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidence of Posterior Capsule Rupture During Phacoemulsification Cataract Surgery Among Patients Treated With Intravitreal Bevacizumab Injections"],"prefix":"10.7759","author":[{"given":"Duaa T","family":"Daradkeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fedaa A","family":"Smadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala  K","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa A","family":"Smadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sura Y","family":"Habashneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaineh A","family":"Shawareb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.36474","article-title":"Bevacizumab: off-label use in ophthalmology","volume":"55","author":"Grisanti S","year":"2007","unstructured":"Grisanti S, Ziemssen F. Bevacizumab: off-label use in ophthalmology. Indian J Ophthalmol. 2007, 55:417-20. 10.4103\/0301-4738.36474","journal-title":"Indian J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2008.40","article-title":"Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema","volume":"23","author":"Ozkiri\u015f A","year":"2009","unstructured":"Ozkiri\u015f A. Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema. Eye (Lond). 2009, 23:616-20. 10.1038\/eye.2008.40","journal-title":"Eye (Lond)"},{"key":"ref3","article-title":"Intravitreal bevacizumab: Indications and complications","volume":"28","author":"Jan S","year":"2016","unstructured":"Jan S, Nazim M, Karim S, Hussain Z. Intravitreal bevacizumab: Indications and complications. J Ayub Med Coll Abbottabad. 2016, 28:364-8.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref4","article-title":"Complication after Intravitreal Bevacizumab (Avastin): Analysis of 1910 injections","volume":"48","author":"Gordon M","year":"2007","unstructured":"Gordon M, Morales CV, Solis AV, et al.. Complication after Intravitreal Bevacizumab (Avastin): Analysis of 1910 injections. IOVS. 2007, 48:88.","journal-title":"IOVS"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0731","article-title":"The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits","volume":"48","author":"Ameri H","year":"2007","unstructured":"Ameri H, Chader GJ, Kim JG, Sadda SR, Rao NA, Humayun MS. The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci. 2007, 48:5708-15. 10.1167\/iovs.07-0731","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2020.1795884","article-title":"Posterior capsule rupture during cataract surgery in eyes receiving intravitreal anti-VEGF injections","volume":"46","author":"Miller DC","year":"2021","unstructured":"Miller DC, Christopher KL, Patnaik JL, Lynch AM, Seibold LK, Mandava N, Taravella MJ. Posterior capsule rupture during cataract surgery in eyes receiving intravitreal anti-VEGF injections. Curr Eye Res. 2021, 46:179-84. 10.1080\/02713683.2020.1795884","journal-title":"Curr Eye Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15089","article-title":"Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysis","volume":"100","author":"Bjerager J","year":"2022","unstructured":"Bjerager J, van Dijk EH, Holm LM, Singh A, Subhi Y. Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysis. Acta Ophthalmol. 2022, 100:614-23. 10.1111\/aos.15089","journal-title":"Acta Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.109","article-title":"Rate of intraoperative complications during cataract surgery following intravitreal injections","volume":"30","author":"Hahn P","year":"2016","unstructured":"Hahn P, Jiramongkolchai K, Stinnett S, Daluvoy M, Kim T. Rate of intraoperative complications during cataract surgery following intravitreal injections. Eye (Lond). 2016, 30:1101-9. 10.1038\/eye.2016.109","journal-title":"Eye (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH,S103443","article-title":"Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells","volume":"10","author":"Jun JH","year":"2016","unstructured":"Jun JH, Sohn WJ, Lee Y, Kim JY. Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells. Clin Ophthalmol. 2016, 10:1167-74. 10.2147\/OPTH,S103443","journal-title":"Clin Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016Lj.jcrs.2011.04.016","article-title":"Quiescent posterior capsule trauma after intravitreal injection: implications for the cataract surgeon","volume":"37","author":"Khalifa YM","year":"2011","unstructured":"Khalifa YM, Pantanelli SM. Quiescent posterior capsule trauma after intravitreal injection: implications for the cataract surgeon. J Cataract Refract Surg. 2011, 37:1364. 10.1016Lj.jcrs.2011.04.016","journal-title":"J Cataract Refract Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.02.014","article-title":"Previous intravitreal therapy is associated with increased risk of posterior capsule rupture during cataract surgery","volume":"123","author":"Lee AY","year":"2016","unstructured":"Lee AY, Day AC, Egan C, et al.. Previous intravitreal therapy is associated with increased risk of posterior capsule rupture during cataract surgery. Ophthalmology. 2016, 123:1252-6. 10.1016\/j.ophtha.2016.02.014","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2019.09.004","article-title":"Risk of posterior capsular rupture during phacoemulsification cataract surgery in eyes with previous intravitreal antivascular endothelial growth factor injections","volume":"46","author":"Nagar AM","year":"2020","unstructured":"Nagar AM, Luis J, Kainth N, Panos GD, Mckechnie CJ, Patra S. Risk of posterior capsular rupture during phacoemulsification cataract surgery in eyes with previous intravitreal antivascular endothelial growth factor injections. J Cataract Refract Surg. 2020, 46:204-8. 10.1016\/j.jcrs.2019.09.004","journal-title":"J Cataract Refract Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016lg.jcr.2009.05.050","article-title":"Management of cataract caused by inadvertent capsule penetration during intravitreal injection of ranibizumab","volume":"35","author":"Saeed MU","year":"2009","unstructured":"Saeed MU, Prasad S. Management of cataract caused by inadvertent capsule penetration during intravitreal injection of ranibizumab. J Cataract Refract Surg. 2009, 35:1857-9. 10.1016lg.jcr.2009.05.050","journal-title":"J Cataract Refract Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.02.006","article-title":"Risk of posterior capsule rupture during cataract surgery in eyes with previous intravitreal injections","volume":"177","author":"Shalchi Z","year":"2017","unstructured":"Shalchi Z, Okada M, Whiting C, Hamilton R. Risk of posterior capsule rupture during cataract surgery in eyes with previous intravitreal injections. Am J Ophthalmol. 2017, 177:77-80. 10.1016\/j.ajo.2017.02.006","journal-title":"Am J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.11.050","article-title":"Cataract formation and other complications of intravitreal triamcinolone for macular edema","volume":"141","author":"Thompson JT","year":"2006","unstructured":"Thompson JT. Cataract formation and other complications of intravitreal triamcinolone for macular edema. Am J Ophthalmol. 2006, 141:629-37. 10.1016\/j.ajo.2005.11.050","journal-title":"Am J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5591865","article-title":"Risk of posterior capsular rupture during phacoemulsification in patients with the history of anti-VEGF intravitreal injections: results from the Pan-American collaborative retina study (PACORES) group","volume":"11","author":"Velez-Montoya R","year":"2021","unstructured":"Velez-Montoya R, Sanchez-Santos I, Galvan-Chavez M, et al.. Risk of posterior capsular rupture during phacoemulsification in patients with the history of anti-VEGF intravitreal injections: results from the Pan-American collaborative retina study (PACORES) group. J Ophthalmol. 2021, 11:5591865. 10.1155\/2021\/5591865","journal-title":"J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000486145","article-title":"2018 update on intravitreal injections: Euretina expert consensus recommendations","volume":"239","author":"Grzybowski A","year":"2018","unstructured":"Grzybowski A, Told R, Sacu S, Bandello F, Moisseiev E, Loewenstein A, Schmidt-Erfurth U. 2018 update on intravitreal injections: Euretina expert consensus recommendations. Ophthalmologica. 2018, 239:181-93. 10.1159\/000486145","journal-title":"Ophthalmologica"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani KG","year":"2013","unstructured":"Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond). 2013, 27:787-94. 10.1038\/eye.2013.107","journal-title":"Eye (Lond)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2014.962167","article-title":"Complications of intravitreal injections in patients with diabetes","volume":"29","author":"Shikari H","year":"2014","unstructured":"Shikari H, Silva PS, Sun JK. Complications of intravitreal injections in patients with diabetes. Semin Ophthalmol. 2014, 29:276-89. 10.3109\/08820538.2014.962167","journal-title":"Semin Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/298598-incidence-of-posterior-capsule-rupture-during-phacoemulsification-cataract-surgery-among-patients-treated-with-intravitreal-bevacizumab-injections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:48:43Z","timestamp":1727419723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/298598-incidence-of-posterior-capsule-rupture-during-phacoemulsification-cataract-surgery-among-patients-treated-with-intravitreal-bevacizumab-injections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.70297","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}